Efficacy of antibodies and enhanced result has actually been found in conjunction with higher affinity polymorphisms of FcγRIIa/CD32a, which aren't expressed on NK cells.27 This may be particularly essential within the context of treatment method with daratumumab. Initially, it was thought that ADCC mediated by NK cells would constitute one https://peterb085tzc8.wikimeglio.com/user